Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC. (nejm.org)

Authors: Zhou F … Zhou C Journal: New England Journal of Medicine Published: 2026-10-25 DOI: https://doi.org/10.1056/NEJMoa2611280